Many patients in Nova Scotia on warfarin no longer have to wait for lab tests to know if their international normalized ratio (INR) results are within acceptable levels.
Study authors suggest avoiding DPP-4 inhibitors in patients with a family history of inflammatory bowel disease and monitoring for persistent gastrointestinal symptoms
